Volume 19, Issue 6 (Nov-Dec 2025)                   mljgoums 2025, 19(6): 5-8 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Prabhu K, Theresa Dsouza R, Devadiga S, Antony B, Dias M. Identification of Candida species isolated from clinical samples by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis. mljgoums 2025; 19 (6) :5-8
URL: http://mlj.goums.ac.ir/article-1-1796-en.html
1- Department of Microbiology, Father Muller Medical College, Mangalore, India
2- Father Muller Research Centre, Mangalore, India
3- Department of Microbiology, Father Muller Medical College, Mangalore, India; Father Muller Research Centre, Mangalore, India
4- Department of Microbiology, Father Muller Medical College, Mangalore, India; Father Muller Research Centre, Mangalore, India , beenafmmc@gmail.com
Abstract:   (1519 Views)
Background: Candida species are responsible for substantial morbidity and mortality among susceptible populations. Contemporary epidemiological data indicate a noticeable shift in infection trends away from Candida albicans (C. albicans) toward non-albicans Candida (NAC) species. The primary objectives of this research were therefore to identify the prevalent Candida species and to assess the efficacy of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) for the identification of these species.
Methods: The standard protocol was employed for processing all routine clinical samples submitted to the bacteriology and mycology departments. Identification of Candida species isolated from diverse clinical specimens was performed using MALDI-TOF MS between September 2022 and November 2023. Subsequently, these findings were recorded in tables and subjected to statistical analysis.
Results: During the study period, a total of 342 Candida species were isolated. Patients diagnosed with candidiasis had a median age of 46.5 years and exhibited a male predominance. NAC species were the most frequently isolated group, with Candida tropicalis (C. tropicalis) (30.40%) as the most common species, followed by Candida parapsilosis (C. parapsilosis) (14.32%). Furthermore, 40 strains of Candida auris (C. auris) were identified over the 15-month duration of the study (11.69%).
Conclusion: The significance of Candida species, encompassing both NAC and novel, emerging drug-resistant strains, necessitates a cautious approach. Compared to conventional and automated systems that rely on biochemical reactions for the speciation of Candida isolates, MALDI-TOF MS offers a potentially advantageous alternative due to its rapid and accurate results.
Full-Text [PDF 462 kb]   (652 Downloads) |   |   Full-Text (HTML)  (2 Views)  
Research Article: Original Paper | Subject: Mycology
Received: 2024/03/26 | Accepted: 2024/12/31 | Published: 2025/12/21 | ePublished: 2025/12/21

References
1. Edwards JE Jr Candida species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1985. p. 2289-306. [View at Publisher]
2. Meyahnwi D, Siraw BB, Reingold A. Epidemiologic features, clinical characteristics, and predictors of mortality in patients with candidemia in Alameda County, California; a 2017-2020 retrospective analysis. BMC Infect Dis. 2022;22(1):843. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Ray A, K AA, Banerjee S, Chakrabarti A, Denning DW. Burden of Serious Fungal Infections in India. Open Forum Infect Dis .2022;9(12):ofac603. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Kaur H, Singh S, Rudramurthy SM, Ghosh AK, Jayashree M, Narayana Y, et al. Candidaemia in a tertiary care center of a developing country: Monitoring possible change in the spectrum of agents and antifungal susceptibility. Indian J Med Microbiol. 2020;38(1):110-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. S Umamaheshwari, Sumana MN. Retrospective analysis on distribution and antifungal susceptibility profile of Candida in clinical samples: a study from Southern India. Front Public Health. 2023;11:1160841. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Prayag PS, Patwardhan S, Panchakshari S, Rajhans PA, Prayag A. The Dominance of Candida auris: A Single-center Experience of 79 Episodes of Candidemia from Western India. Indian J Crit Care Med. 2022;26(5):560-3. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Eghtedar Nejad E, Ghasemi Nejad Almani P, Mohammadi MA, Salari S. Molecular identification of Candida isolates by Real-time PCR-high-resolution melting analysis and investigation of the genetic diversity of Candida species. J Clin Lab Anal. 2020;34(10):e23444. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Maenchantrarath C, Nutalai D, Samosornsuk W, Sakoonwatanyoo P. Identification of yeasts from clinical samples using MALDI-TOF MS. Vajira Med J: Journal of Urban Medicine. 2020;64(4):297-310. [View at Publisher] [DOI] [Google Scholar]
9. Lau AF. Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification. Clin Lab Med. 2021;41(2):267-83. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Pereira LC, Correia AF, da Silva ZDL, de Resende CN, Brandão F, Almeida RM, et al. Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence. Eur J Clin Microbiol Infect Dis. 2021;40(8):1681-93. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Clinical and Laboratory Standards Institute (CLSI). Methods for the identification of cultured microorganisms using Matrix-assisted laser desorption ionization-time of flight mass spectrometry. 1st ed. CLSI guidelines M58. Wayne PA: Clinical and laboratory institute 2017. Available from: https://clsi.org/shop/standards/m58/. [View at Publisher]
12. Singh DP, Kumar Verma R, Sarswat S, Saraswat S. Non-Candida albicans Candida species: virulence factors and species identification in India. Curr Med Mycol. 2021;7(2):8-13. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Gautam G, Rawat D, Kaur R, Nathani M. Candidemia: Changing dynamics from a tertiary care hospital in North India. Curr Med Mycol. 2022;8(1):20-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Anita, Kumar S, Pandya HB. Speciation and Antifungal Susceptibility Testing of Candida isolated from Immunocompromised Patients of a Tertiary Care Centre in Gujarat, India. J Pure Appl Microbiol. 2023;17(1):427-33. [View at Publisher] [DOI] [Google Scholar]
15. Keighley C, Garnham K, Harch SAJ, Robertson M, Chaw K, Teng JC, et al. Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory. Curr Fungal Infect Rep. 2021;15(3):116-26. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Moore R, Lie L, Pua H, Slade DH, Rangel S, Davila A, et al. 1225. The Perfect Storm: A Hardy and Lethal Pathogen and a Unit Filled with Immunocompromised Patients with Large Open Wounds. Troubles with Candida Auris in a Burn Intensive Care Unit. Open Forum Infect Dis. 2022;9(2):ofac492.1057. [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.